Asymptomatic Carotid Artery Plaque Study "ACAPS"

Completed

Phase N/A Results

Summary of Purpose

This study tested the effect of the HMG-CoA reductase inhibitor, lovastatin, on early-stage carotid atherosclerosis (as detected by B-mode ultrasonography) in 919 asymptomatic men and women, 40-79 years of age with moderately elevated LDL cholesterol.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 August 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Double-blind, placebo-controlled, factorially designed study of 919 patients.

Contacts

Not available